Literature DB >> 35237984

Monitoring Cellularity and Expression of Key Markers in Atherosclerotic Plaques.

Yee-Hung Chan1, Reem Alotibi2, Alaa Alahmadi1, Dipak P Ramji1.   

Abstract

Atherosclerotic plaques are highly diverse and heterogeneous structures, even within the same individual, and can vary depending on its anatomical location within the vascular bed. Early in the disease and throughout its progression, immune cells infiltrate the lesion, contributing to the plaque phenotype via different mechanisms. Detailed characterization of constituent cell populations within plaques is hence required for more accurate assessment of disease severity and inflammatory burden. A wide range of fluorophore-conjugated antibodies targeted to key cell types implicated in all stages of the disease are commercially available, enabling visualization of the dynamic cellular landscape present within lesions. This chapter describes the use of immunofluorescence staining of atherosclerotic plaque sections to study plaque cellularity and expression of key markers.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Antibodies; Immunofluorescence; Macrophages; Smooth muscle cells; T cells

Mesh:

Year:  2022        PMID: 35237984     DOI: 10.1007/978-1-0716-1924-7_30

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  7 in total

Review 1.  An Introduction to Performing Immunofluorescence Staining.

Authors:  Kyuseok Im; Sergey Mareninov; M Fernando Palma Diaz; William H Yong
Journal:  Methods Mol Biol       Date:  2019

2.  MMP-2 and MMP-9 are prominent matrix metalloproteinases during atherosclerosis development in the Ldlr(-/-)Apob(100/100) mouse.

Authors:  Dick Wågsäter; Chaoyong Zhu; Johan Björkegren; Josefin Skogsberg; Per Eriksson
Journal:  Int J Mol Med       Date:  2011-05-06       Impact factor: 4.101

Review 3.  Collagens in the progression and complications of atherosclerosis.

Authors:  Eser Adiguzel; Pamela J Ahmad; Christopher Franco; Michelle P Bendeck
Journal:  Vasc Med       Date:  2009-02       Impact factor: 3.239

Review 4.  A perspective on targeting inflammation and cytokine actions in atherosclerosis.

Authors:  Yee-Hung Chan; Dipak P Ramji
Journal:  Future Med Chem       Date:  2020-03-16       Impact factor: 3.808

Review 5.  Cytokines: roles in atherosclerosis disease progression and potential therapeutic targets.

Authors:  Joe We Moss; Dipak P Ramji
Journal:  Future Med Chem       Date:  2016-06-30       Impact factor: 3.808

Review 6.  Pathophysiology and treatment of atherosclerosis : Current view and future perspective on lipoprotein modification treatment.

Authors:  S C Bergheanu; M C Bodde; J W Jukema
Journal:  Neth Heart J       Date:  2017-04       Impact factor: 2.380

Review 7.  Nutraceuticals as therapeutic agents for atherosclerosis.

Authors:  Joe W E Moss; Jessica O Williams; Dipak P Ramji
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-02-14       Impact factor: 5.187

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.